BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Reports

Anthony Elgamal: Redefining First-Line Treatment in EGFR-Mutated Lung Cancer

BioPharma APAC speaks with Anthony Elgamal, Vice President of Oncology, Johnson & Johnson Innovative Medicine Asia Pacific, on th...

October 13, 2025 | Expert Insight

Asia-Pacific Takes the Lead in Global Biopharma Resilience: Cytiva’s 2025 Index Highlights Regional Rise Amid Global Slowdown

The 2025 Global Biopharma Index released by Cytiva, a Danaher company, reveals that while the global biopharma ecosystem has experienced a modest decline i...

October 08, 2025 | Analysis

Turning Signals into Cures: The Big Data Blueprint for Cell Therapy Factories

Cell therapy manufacturing is entering a data-driven era, as the industry grapples with complex production processes, high costs, and the need for personal...

October 07, 2025 | Analysis

HKUST Uncovers Genetic Variant Driving Alzheimer’s Risk Among Ethnic Chinese

A landmark study conducted by The Hong Kong University of Science and Technology (HKUST) has demonstrated that a genetic variant, TREM2 ...

October 06, 2025 | News

Daiichi Sankyo and AstraZeneca’s ENHERTU delivers second positive phase 3 win in HER2 positive early breast cancer

Second positive phase 3 trial of Daiichi Sankyo and AstraZeneca’s ENHERTU in HER2 positive early breast cancer reinforces its potential to become...

September 30, 2025 | News

COREE Identifies First-Ever Microbiome Biomarkers for Diabetes and Obesity Patients

COREE announced on September 15 that it had, for the first time in the world, identified microbiome biomarkers specific to diabetes and obesity p...

September 29, 2025 | News

QIAGEN and APAGE Convene Asia-Pacific Experts to Set New Consensus on GI Infection Diagnostics

QIAGEN, in collaboration with APAGE, organized a regional meeting in Malaysia to share insights in GI diagnostics Over 10 leading key opinio...

September 24, 2025 | News

CorestemChemon Phase 3 ALSummit Trial Shows Subgroup Benefit of Neuronata-R® in ALS

CorestemChemon Inc. announced that it has presented key findings from the Phase 3 ALSummit trial of Neuronata-R® (lenzumestrocel) an autolo...

September 22, 2025 | News

Skyhawk’s SKY-0515 Shows 62% Reduction in Mutant Huntingtin at Day 84 in Huntington’s Disease Trial

SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral dose Additional finding...

September 18, 2025 | News

Contrast-Enhanced Ultrasound Shows Promise for Early Pancreatic Cancer Detection

A new study shows that contrast enhanced ultrasound (CEUS) techniques offer an encouraging option for noninvasively detecting pancreatic cancer in its earl...

September 11, 2025 | Report

Siemens Healthineers–YouGov Survey Reveals Fragmented Cancer Care Pathway in Southeast Asia, Underscoring Need for Integrated Solutions

YouGov survey finds strong belief in value of early detection (78%) but low screening uptake (26%) 80% of respondents aware post-treatment care exists...

September 10, 2025 | Report